Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Abbott Laboratories

Start price
Target price
Perf. (%)
€93.94
19.10.20
-
04.11.21
-0.70%
20.06.21

buy
AbbVie Inc.

Start price
Target price
Perf. (%)
€73.73
19.10.20
-
04.11.21
30.01%
20.06.21

Novacyt S.A.

Start price
Target price
Perf. (%)
€10.10
19.10.20
€4.00
30.10.20
14.26%
30.10.20

Probably not worthwhile Investment
buy
Mologen AG

Start price
Target price
Perf. (%)
€0.084
19.10.20
-
04.11.21
-16.15%
27.12.20

buy
Evotec SE

Start price
Target price
Perf. (%)
€23.57
19.10.20
-
04.11.21
25.20%
11.03.21

Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Novacyt S.A.

Start price
Target price
Perf. (%)
€10.10
19.10.20
-
04.11.21
-10.69%
18.11.20

Novacyt S.A.

Start price
Target price
Perf. (%)
€10.10
19.10.20
-
04.11.21
-72.31%
05.11.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Heat Biologics Inc.

Start price
Target price
Perf. (%)
€7.29
19.10.20
€14.00
31.10.20
1.63%
31.10.20

buy
Genmark Diagnostics

Start price
Target price
Perf. (%)
€9.65
19.10.20
€12.00
02.11.20
12.95%
02.11.20

Could be worthwhile Investment >10% per year
buy
Pacific Biosciences of California Inc.

Start price
Target price
Perf. (%)
€12.20
19.10.20
€15.00
02.11.20
-6.56%
02.11.20

Could be worthwhile Investment >10% per year
buy
Cutera Inc.

Start price
Target price
Perf. (%)
€16.30
19.10.20
€20.00
02.11.20
-0.61%
02.11.20

Could be worthwhile Investment >10% per year
buy
CHF Solutions Inc

Start price
Target price
Perf. (%)
-
19.10.20
€10.00
02.11.20
-
02.11.20

Could be very worthwhile Investment >20% year
buy
Theranexus

Start price
Target price
Perf. (%)
€9.72
19.10.20
€12.00
04.11.21
-30.35%
05.11.21

buy
Epigenomics AG NA

Start price
Target price
Perf. (%)
€0.51
18.10.20
€1.00
02.11.20
20.00%
02.11.20

Could be worthwhile Investment >10% per year
Capable Management
Very good company culture
Innovative
Theradiag S.A.

Start price
Target price
Perf. (%)
€4.91
18.10.20
€2.00
04.11.21
-61.38%
26.06.21

Theranexus

Start price
Target price
Perf. (%)
€9.72
18.10.20
€4.00
04.11.21
11.32%
26.06.21

GNI Group Ltd

Start price
Target price
Perf. (%)
€24.00
18.10.20
€12.00
04.11.21
-35.42%
26.06.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
Below average Management
Little innovation
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€5.70
18.10.20
€2.00
04.11.21
-35.79%
26.06.21

Probably not worthwhile Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
buy
Acelrx Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€31.82
18.10.20
-
31.10.20
-7.45%
31.10.20

Risky Investment
Aphria Inc.

Start price
Target price
Perf. (%)
€3.95
18.10.20
-
31.10.20
-0.95%
31.10.20

buy
Omeros Corp.

Start price
Target price
Perf. (%)
€9.38
18.10.20
€14.00
04.11.21
-33.93%
05.11.21

buy
Bayer AG

Start price
Target price
Perf. (%)
€44.90
18.10.20
€50.00
04.11.21
6.54%
12.10.21

Could be worthwhile Investment >10% per year
buy
Dr. Reddy's Laboratories Ltd. ADR

Start price
Target price
Perf. (%)
€57.50
18.10.20
€65.00
04.11.21
-3.48%
05.11.21

buy
Immunogen Inc.

Start price
Target price
Perf. (%)
€4.99
18.10.20
€8.00
04.11.21
17.07%
05.11.21

buy
Paion AG

Start price
Target price
Perf. (%)
€2.55
17.10.20
€5.00
04.11.21
-27.69%
05.11.21

Innovative
Future proof or reliable business model
Could be very worthwhile Investment >20% year
Strong uniques